Effectiveness of maintaining oxygenation of a new high flow nasal cannula for endoscopic retrograde cholangiopancreatography during intravenous anesthesia
This study aims to generate evidence supporting the utility of HFNC as a potential therapeutic device for ERCP under sedation by determining whether the incidence rates of hypercapnia and hypoxemia are lower in the HFNC group than in the LFNC group. TRIAL REGISTRATION {2A,2B}: The study was registered as jRCTs072240096 on January 16, 2025.
Authors
- Hisamitsu Miyaaki (ORCID: https://orcid.org/0000-0002-8067-4376)
- Ryota Sagami (ORCID: https://orcid.org/0000-0003-4961-3521)
- Kosuke Takahashi (ORCID: https://orcid.org/0000-0003-2361-5043)
- 鮎瀬 卓郎
- Eisuke Ozawa (ORCID: https://orcid.org/0000-0002-2226-781X)
- Yusuke Ishida (ORCID: https://orcid.org/0000-0002-1422-8685)
- Y. Hiroshima (ORCID: https://orcid.org/0009-0003-5525-7014)
- Takehiko Koga
- Masatoshi Murakami
- Nao Fujimori
Institutions
- Kagoshima University (JP)
- Kyushu University (JP)
- Oita University (JP)
- Fukuoka University (JP)
- Nagasaki University Hospital (JP)
- Nagasaki University (JP)
Publication Details
- Journal
- Trials
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1186/s13063-025-09421-5
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00